Shares of medical device and diabetes care stocks are trading higher in reaction to the presentation of SELECT data by Novo Nordisk. Raymond James said it did not believe there were any major surprises and the data could be seen as 'modestly de-risking.'
Portfolio Pulse from Benzinga Newsdesk
Medical device and diabetes care stocks are trading higher following the presentation of SELECT data by Novo Nordisk. Raymond James commented that the data presented did not contain major surprises and could be considered as 'modestly de-risking' for the sector.
November 13, 2023 | 4:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories, a player in the medical device and diabetes care sector, may see a positive short term impact on its stock price following the SELECT data presentation by Novo Nordisk.
As a key company in the diabetes care market, Abbott Laboratories is likely to benefit from the positive sentiment generated by the SELECT data presentation, which is seen as reducing risk in the sector.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
DexCom, Inc., specializing in glucose monitoring systems, may experience a short term uplift in its stock price due to the positive reception of Novo Nordisk's SELECT data.
DexCom, as a prominent company in glucose monitoring, stands to gain from the industry's positive outlook following the SELECT data presentation, which is perceived as lowering risk.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Medtronic plc, a leader in medical technology, services, and solutions, including diabetes care, may see its stock price positively impacted in the short term by the SELECT data from Novo Nordisk.
Medtronic's involvement in diabetes care suggests that the company's stock might rise following the industry-positive SELECT data presentation, which is seen as mitigating risk.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Penumbra, Inc., a healthcare company, may see a neutral to positive short term impact on its stock price following the SELECT data presentation by Novo Nordisk.
While Penumbra is not exclusively focused on diabetes care, the overall positive sentiment in the medical device sector could have a favorable impact on its stock.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50
POSITIVE IMPACT
Insulet Corporation, engaged in the development of insulin management systems, may experience a positive short term impact on its stock price due to the industry-positive SELECT data from Novo Nordisk.
Insulet Corporation, being directly involved in insulin management, is likely to benefit from the positive industry sentiment following the SELECT data presentation.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Tandem Diabetes Care, Inc., a medical device company focused on insulin delivery systems, may see its stock price positively influenced in the short term by the SELECT data from Novo Nordisk.
Tandem Diabetes Care's focus on insulin delivery systems positions it to gain from the positive market reaction to the SELECT data presentation, which is viewed as reducing sector risk.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70